Maravai Lifesciences Holdings (MRVI) Exchange Rate Effect (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Exchange Rate Effect of $30000.0 for Q1 2026, down 58.9% year-over-year from $73000.0 in Q1 2025, and up 114.29% quarter-over-quarter from $14000.0 in Q4 2025.
Analysis
Maravai Lifesciences Holdings (MRVI) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Exchange Rate Effect history runs 4 years deep, the most recent figure standing at $30000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 58.9% year-over-year to $30000.0; the TTM figure through Mar 2026 stood at -$75000.0 (down 202.74% YoY), while the FY2025 annual figure was -$32000.0, changed N/A from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $30000.0, up from $14000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $73000.0 in Q1 2025, with the low at -$111000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Maravai Lifesciences Holdings | 1.09 Bn | 1.02 Bn | 20.65 Mn | 17,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17,000.00 |
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -111,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2021 | -133,000.00 |
| Sep 30, 2021 | 32,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 7,000.00 |
| Dec 31, 2020 | 48,000.00 |
| Sep 30, 2020 | 30,000.00 |
| Jun 30, 2020 | 11,000.00 |
| Mar 31, 2020 | -72,000.00 |